Partner News
The section includes updates from partner organizations on related advocacy efforts.
Materials in this section
HCV Models of Care – Moving Towards Elimination - Webinar Materials Now Available Online
Webinar hosted by the Hepatitis C Partnership for Control and Treatment (Hepatitis C PACT) in partnership with the WHO Regional Offices for the Western Pacific and South-East Asia. More
Promoting Interventions for Viral Hepatitis and Harm Reduction in PEPFAR COPs - Webinar Materials in English, Portuguese and French
PEPFAR Watch webinar co-hosted by Treatment Action Group, the International Network of People Who Use Drugs, Harm Reduction International, and the World Hepatitis Alliance. More
Call for New Global Long-Acting Technologies CAB Members from Asian, Central African, Eastern European, MENA, and Latin American Countries
TAG and AfroCAB announce an expanded call for a new cross-disease LAT CAB focused on malaria, hepatitis C, and latent TB. Apply now! Applications accepted on a rolling basis. More
Innovations in HCV Diagnostics: Real-World Implementation - 4 Key Takeaways
Virtual satellite session at 2021 International Conference on Health and Hepatitis Care in Substance Users, chaired by Treatment Action Group, The Kirby Institute, UNSW Sydney, FIND, and INPUD. More
Three Additional Generic Manufacturing Partners Join Efforts to Increase Access to Generic Hepatitis C Treatment Glecaprevir/Pibrentasvir
The Medicines Patent Pool signed three new sublicence agreements with generic companies to develop, manufacture and supply high-quality affordable versions of glecaprevir/pibrentasvir. More
Medicines Patent Pool Secures its First Licence on Promising Long-Acting Technologies for Malaria, TB, and Hepatitis C
The licence covers the patents and expertise of promising long-acting injectable technologies that could be applied in three disease areas with a high prevalence in LMICs. More
Have a Heart, Save My Liver! Who Has Access to the Cure in Africa?
TAG’s HCV Community Engagement Officer presented new data on the registration of the hepatitis C cure at the Conference on Liver Disease in Africa (COLDA) 2021. More
First Hepatitis C Treatment Developed Through South-South Cooperation Registered in Malaysia
New treatment combination for hepatitis C virus is an additional affordable option for millions still waiting for access to lifesaving treatments in middle-income countries. More
Russia Stuns UN High-Level Meeting on AIDS by Refusing to Support Consensus Declaration
Russia proposed last-minute oral amendments to the meeting’s final declaration – removing references to “rights”; the decriminalization of sex work; and harm reduction in the context of HIV response. More
Call for Applications! Malaria, Hepatitis C, and Latent TB Infection Long-Acting Technologies Community Advisory Board
TAG and AfroCAB are excited to share a call for a new cross-disease long-acting technologies CAB focused on malaria, hepatitis C, and latent TB infection. Apply now! Deadline: 21 May 2021. More